Recent evidence reveals a more complex regulatory role for TCF7L2 gene and its adipose tissue expression in mediating WNT pathway related metabolic effects that are associated with Insulin resistance and T2DM. The gene discussed is TCF7L2; the disease is Insulin resistance.